This is a $5,217.72 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of Pfizer COVID-19 vaccine doses (0.9mL) for the 2023-2024 period, under the FDA's Emergency Use Authorization. This award does not have a set-aside designation. AmerisourceBergen holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical through December 2025, which...
This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit pharmaceutical distribution company. The order is for the supply of 0.9 mL doses of the Pfizer COVID-19 vaccine under Emergency Use Authorization (EUA) for a period of 6 months to 4 years, with a completion date of March 1, 2024 and a potential value of $3,124.28. This order is not set aside for any specific business...
This is a $1,129.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 0.9 ML Pfizer COVID-19 vaccines from 2024-2025. The contract has an ultimate completion date of February 25, 2025 and was awarded on February 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 0.9ML Pfizer COVID-19 vaccine doses for the 2023-2024 period under the Emergency Use Authorization (EUA). The contract has a ceiling value of $1,069.25 and a period of performance through April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not associated with any set-aside...
This is a $1,622.03 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order is for the procurement of Pfizer COVID-19 vaccines, with a period of performance from January 2024 to January 2025. The contract does not have a set-aside designation, indicating open competition. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $2,162.70 contract is for the delivery of Pfizer COVID-19 vaccines in 0.9 mL doses, with a performance period from February 2023 through February 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen...
This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award is for the delivery of Pfizer COVID-19 vaccines and related medical supplies, with a ceiling value of $1,525.97 and a period of performance through April 12, 2024. The award is part of Amerisourcebergen's larger indefinite delivery contract (IDC) with...
This is a $1,129.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pfizer COVID-19 vaccines from 2024 to 2025, with an ultimate completion date of February 18, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of 0.9 ML doses of Pfizer's COVID-19 vaccine for the 2023-2024 period, under an Emergency Use Authorization (EUA). The contract has a firm fixed price of $25,691.25 and a completion date of April 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
This is a $1,069.25 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,309,714 units of the Pfizer COVID-19 vaccine (0.9 mL) under an Emergency Use Authorization (EUA) over a period of 6 months to 4 years. The contract is a Firm Fixed Price (FFP) arrangement with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has...